Oncimmune Non Current Assets Total from 2010 to 2024

Stocks . UK . 
Stock . Oncimmune Holdings plc
ONC Stock   14.75  0.05  0.34%   
Oncimmune Holdings' Non Current Assets Total are increasing over the years with slightly volatile fluctuation. Non Current Assets Total are expected to dwindle to about 2.6 M. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2010-12-31
Previous Quarter
3.3 M
Current Value
2.6 M
Quarterly Volatility
2.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Oncimmune Holdings financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Oncimmune Holdings' main balance sheet or income statement drivers, such as Depreciation And Amortization of 256.3 K, Interest Expense of 2.4 M or Selling General Administrative of 474.1 K, as well as many indicators such as . Oncimmune financial statements analysis is a perfect complement when working with Oncimmune Holdings Valuation or Volatility modules.
  
This module can also supplement various Oncimmune Holdings Technical models . Check out the analysis of Oncimmune Holdings Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C

Other Information on Investing in Oncimmune Stock

Oncimmune Holdings financial ratios help investors to determine whether Oncimmune Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Oncimmune with respect to the benefits of owning Oncimmune Holdings security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY